CITIC Selects Fincad for Analytics

beijing-web
CITIC is one of the leading investment banks in China by a variety of factors.

CITIC will use F3 in its Hong Kong and mainland China presences, primarily to provide risk sensitivities on its exotic and vanilla portfolios.

"The Fincad professional services team was very helpful in seamlessly implementing the F3 analytics solution," says Xu Xing Hai, director of the equity derivatives business at CITIC. "Between the training we received and how easily their solution fit into our current systems, we were operational in just a few months. This was instrumental in enabling us to get our new business off the ground as quickly as planned."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Deutsche Börse democratizes data with Marketplace offering

Deutsche Börse Group is set to unveil its Marketplace, a one-stop data shop designed to simplify and streamline data acquisition and consumption for its clients, while also surfacing data from across the firm to its own users. Jan Stiebing and Sven…

The IMD Wrap: The growing data catalogue space

With their potential to manage costs and surface strategic datasets, it’s no wonder Max gets excited about data catalogs. This week, he takes a look at a new startup entering the space.

The IMD Wrap: Taking stock of inventory management

With market data and associated costs typically representing a firm’s third-largest expense, there’s a lot of incentive to manage data and its usage more efficiently. Max flings open his fridge to illustrate what’s new in this space.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here